Karen L. Smith Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Karen L. Smith.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Karen L. Smith. Karen L. Smith is a Director in ANTARES PHARMA, INC. ($ATRS) and a Director in SANGAMO THERAPEUTICS, INC ($SGMO) and a EVP, R&D and CMO in Jazz Pharmaceuticals plc ($JAZZ) and a Global Head of R&D and CMO in Jazz Pharmaceuticals plc ($JAZZ) and a Director in ACCELERON PHARMA INC ($XLRN) and a Director in Sucampo Pharmaceuticals, Inc. ($SCMP).

Over the past year Karen L. Smith has been an insider in 3 companies. The total value of shares held by Karen L. Smith in these companies amounts to $227,496.

Karen L. Smith Director
ACCELERON PHARMA INC
Director
ANTARES PHARMA, INC.
EVP, R&D and CMO, Global Head of R&D and CMO
Jazz Pharmaceuticals plc
Director
SANGAMO THERAPEUTICS, INC
Director
Sucampo Pharmaceuticals, Inc.
$ 227496 The total value of shares held by Karen L. Smith
Insider Rank

Karen L. Smith ranks 27,597 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: CONNAUGHT HOUSE, 1 BURLINGTON RD, FL. 4 DUBLIN 4 Ireland

Companies in which Karen L. Smith is an Insider

ACCELERON PHARMA INC

Trading Symbol: XLRN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Karen L. Smith: Director
Holdings: 2,939 shares
Current Value: $69,772
Latest Transaction: Jan 24 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 2,939
Shares Sold: 0
Share Difference: +2,939
Value Difference: $0

ANTARES PHARMA, INC.

Trading Symbol: ATRS
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Karen L. Smith: Director
Holdings: 54,193 shares
Current Value: $119,225
Latest Transaction: Jun 15 2020
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 84,413
Shares Sold: 0
Share Difference: +84,413
Value Difference: -$235,002

Jazz Pharmaceuticals plc

Trading Symbol: JAZZ
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen L. Smith: EVP, R&D and CMO, Global Head of R&D and CMO
Holdings: 28,474 shares
Current Value: $3,560,674
Latest Transaction: Mar 07 2018
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 4x
Shares Bought: 18,245
Shares Sold: 2,033
Share Difference: +16,212
Value Difference: +$52,923

SANGAMO THERAPEUTICS, INC

Trading Symbol: SGMO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Karen L. Smith: Director
Holdings: 10,000 shares
Current Value: $38,500
Latest Transaction: May 20 2020
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 10,000
Shares Sold: 0
Share Difference: +10,000
Value Difference: $0

Sucampo Pharmaceuticals, Inc.

Trading Symbol: SCMP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen L. Smith: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 13 2018
$SCMP Market Capitalization: $496.69M
$SCMP Previous Close: $11.35

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Karen L. Smith

Sentiment: All, XLRN, ATRS, JAZZ, SGMO, SCMP

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 15 2020ATRSANTARES PHARMA, IN ...Smith Karen L.DirectorOption ExerciseA2.7358,246159,01258,246
Jun 15 2020ATRSANTARES PHARMA, IN ...Smith Karen L.DirectorGrantA2.7330,22082,50154,19324 K to 54.2 K (+126.06 %)
Jun 15 2020ATRSANTARES PHARMA, IN ...Smith Karen L.DirectorOption ExerciseA2.7358,246159,01258,246
Jun 15 2020ATRSANTARES PHARMA, IN ...Smith Karen L.DirectorGrantA2.7330,22082,50154,19324 K to 54.2 K (+126.06 %)
May 20 2020SGMOSANGAMO THERAPEUTI ...Smith Karen L.DirectorOption ExerciseA10.4615,000156,90015,000
May 20 2020SGMOSANGAMO THERAPEUTI ...Smith Karen L.DirectorGrantA0.002,500010,0007.5 K to 10 K (+33.33 %)
Jan 24 2020XLRNACCELERON PHARMA I ...Smith Karen L.DirectorOption ExerciseA52.998,185433,7238,185

View all Karen L. Smith insider transactions.